Survival in Medically Treated Patients with Homozygous β-Thalassemia

Abstract

The prognosis for survival without cardiac disease is excellent for patients with thalassemia major who receive regular transfusions and whose serum ferritin concentrations remain below 2500 ng per milliliter with chelation therapy.